Treatments for Lewy Body Dementias (NINDS/NIA)

• Published date: 03 December 2020
• DOI: http://doi.org/10.1002/fgc.31441
• Date: 03 December 2020

Federal Grants & Contracts ■ December 3, 2020 Page 7

© 2020 Wiley Periodicals LLC • All rights reserved • DOI: 10.1002/fgc

Grants alert (cont.)

Reducing Revisionist State Biological

and Chemical Weapons Threats (DOS)

Scope: The State Department’s Bureau of International

Security-Nonproliferation seeks applications for the

FY2021 Reducing Revisionist State Biological and

Chemical Weapons Threats announcement to identify

and disrupt the ability of revisionist proliferator states

to develop chemical and biological weapons (CBW)

capabilities.

Deadline: Jan. 29, 2021.

Funds: $2 million total for awards ranging from $50,000

to $500,000.

Eligibility: Colleges and universities, for-prot

organizations and nonprot organizations, among others.

Areas: DOS said it seeks programmatic proposals

supporting the following lines of effort: Open-Source

Data and Related Training to Identify Potential Illicit

CBW Facilitation Networks, Disruption of Potential Illicit

Revisionist State BW Supply Chain Capabilities, and

Protection of Dual-Use CBW-Relevant Expertise and

Tacit Knowledge.

➜ www.grants.gov; FON# SFOP0007378

Qatari Audience Analysis (DOS)

Scope: The State Department’s U.S. Mission to Qatar

seeks applications for the Qatari Audience Analysis

announcement to conduct a comprehensive audience

analysis study on Qataris in Qatar and implement a

program to help address the underlying factors identied

in the study.

Deadline: Jan. 15, 2021.

Funds: One award of up to $250,000.

Eligibility: Nonprot and nongovernmental

organizations.

Areas: DOS said examples of such activities can

include: gathering information about the Qatari

population, its likes and dislikes, favorite pastime

activities and places to visit, etc., and learning how

Qataris engage with the media, how they communicate

with one another, where they convene and what voices

they consider to be credible. This would be followed

by developing a strategy to help improve information

dissemination and content creation on the right

platforms for greater reach to target audiences.

➜ www.grants.gov; FON# PAS-QAT-FY21-001

Stephen I. Katz Early Stage Investigator

Research Project Grant (NIH)

Scope: The National Institutes of Health seeks (R01)

research project grant applications for the Stephen I.

Katz Early Stage Investigator Research Project Grant

announcement to support an innovative project that

represents a change in research direction for an early-

stage investigator (ESI) and for which no preliminary

data exists.

Deadline: Jan. 26, 2021; May 26, 2021; and Sept. 28,

2021.

Funds: The number of awards depends on

appropriations and the submission of a sufficient

number of quality applications. The maximum project

period is ve years.

Eligibility: Colleges and universities; for-prot

organizations, including small businesses; nonprot

organizations; and state, local, special district and Native

American tribal governments; among others.

Areas: NIH said the proposed research projects can rely

on the Program Director/Principal Investigator’s (PD/PI’s)

prior work and expertise as its foundation but must not

be an incremental advancement, expansion or extension

of a previous research effort. The change in research

direction could involve, for example, a new approach,

methodology, technique, discipline, therapeutic target

and/or new paradigm, different from the ESI’s previous

research efforts. Importantly, the proposed direction

must represent a change in research direction for the

PD/PI.

➜ www.grants.gov; FON# PAR-21-038

Treatments for Lewy Body Dementias (NINDS/

NIA)

Scope: The National Institute of Neurological

Disorders and Stroke and the National Institute

on Aging seek (U01) research project cooperative

agreement applications for the Treatments for Lewy

Body Dementias announcement to conduct exploratory

clinical trials designed to test new treatments for patients

with Lewy Body Dementia (LBD).

Deadline: Letters of Intent, Feb. 2, 2021; proposals,

March 2, 2021.

Funds: $2 million total in FY2021 for one to two awards.

The maximum project period is ve years.

Eligibility: Colleges and universities; for-prot

organizations, including small businesses; nonprot

organizations; and state, local, special district and Native

American tribal governments; among others.

Areas: NINDS/NIA said applicants may propose

to conduct either Phase I or Phase II clinical trials,

depending on the developmental stage of the potential

therapeutic. All applications should justify that: (1) the

proposed clinical trial addresses an important unmet

medical need for patients with LBD, (2) the proposed

treatment has a plausible biological mechanism of

action relevant for LBD and (3) sufficient in vivo and/or in

vitro data exists for the proposed treatment to be used in

(more)